Literature DB >> 11833080

Seek protein which can interact with hepatitis B virus X protein from human liver cDNA library by yeast two-hybrid system.

Xiao-Zhong Wang1, Xiang-Rong Jiang, Xiao-Chun Chen, Zhi-Xing Chen, Dan Li, Jian-Yin Lin, Qi-Min Tao.   

Abstract

AIM: To seek the X associated protein (XAP) with the constructed bait vector pAS2-1X from normal human liver cDNA library.
METHODS: The X region of the HBV gene was amplied by PCR and cloned into the eukaryotic expression vector pAS2-1. The reconstituted plasmid pAS2-1X was transformed into the yeast cells and the expression of X protein (pX) was confirmed by Western blot analysis. Yeast cells were cotransformed with pAS2-1X and the normal human liver cDNA library and were grown in selective SC/-trp-leu-his-ade medium, the second screen was performed with the LacZ report gene. Furthermore, segregation analysis and mating experiment were performed to eliminate the false positive and the true positive clones were selected for PCR and sequencing.
RESULTS: Reconstituted plasmid pAS2-1X including the anticipated fragment of X gene was proved by auto-sequencing assay. Western blot analysis showed that reconstituted plasmid pAS2-1X expressed BD:X fusion protein in yeast cells. Of 5 x 10(6) transformed colonies screened,65 grew in the selective SC/-trp-leu-his-ade medium, 5 scored positive for beta-gal activity, and only 2 remaining clones passed through the segregation analysis and mating experiment. Sequence analysis identified that two clones contained similar cDNA fragment:GAACTTGCG.
CONCLUSION: The short peptide(glutacid-leucine-alanine)is a possible required site for XAP binding to pX. Normal human liver cDNA library has difficulties in expressing the integrated XAP on yeast cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11833080      PMCID: PMC4656635          DOI: 10.3748/wjg.v8.i1.95

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

1.  Expression of IGF- II, p53, p21 and HBxAg in precancerous events of hepatocarcinogenesis induced by AFB1 and/or HBV in tree shrews.

Authors:  Liu-Liang Qin; Jian-Jia Su; Yuan Li; Chun Yang; Ke-Chen Ban; Rue-Qi Yian
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Overexpression of P-glycoprotein in hepatocellular carcinoma and its clinical implication.

Authors:  Xian-Bing Kong; Zu-Kui Yang; Li-Jian Liang; Jie-Fu Huang; Han-Liang Lin
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

3.  HBx-DNA probe preparation and its application in study of hepatocarcinogenesis.

Authors:  Feng-Guang Gao; Wen-Sheng Sun; Ying-Lin Cao; Li-Ning Zhang; Jing Song; Hua-Fen Li; Shi-Kun Yan
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

4.  Phase tissue intercellular adhesion molecule-1 expression in nude mice human liver cancer metastasis model.

Authors:  Jing-Jing Sun; Xin-Da Zhou; Yin-Kun Liu; Ge Zhou
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

5.  Relationship between expression of CD44v6 and nm23-H1 and tumor invasion and metastasis in hepatocellular carcinoma.

Authors:  Cheng-Zhi Xiao; Yi-Min Dai; Hong-Yu Yu; Jian-Jun Wang; Can-Rong Ni
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

6.  Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential.

Authors:  Z Rahmani; K W Huh; R Lasher; A Siddiqui
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Proteasome complex as a potential cellular target of hepatitis B virus X protein.

Authors:  J Huang; J Kwong; E C Sun; T J Liang
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

9.  Hepatitis B virus X protein interacts with a probable cellular DNA repair protein.

Authors:  T H Lee; S J Elledge; J S Butel
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Liver-specific enhancer II is the target for the p53-mediated inhibition of hepatitis B viral gene expression.

Authors:  H Lee; H T Kim; Y Yun
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

View more
  6 in total

1.  Investigation of HGV and TTV infection in sera and saliva from non-hepatitis patients with oral diseases.

Authors:  Jie Yan; Li-Li Chen; Yong-Liang Lou; Xiao-Zhi Zhong
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

2.  Transfection and expression of hepatitis B virus x gene and its effect on apoptosis in HL-7702 cells.

Authors:  Hong-Ying Chen; Nan-Hong Tang; Xiu-Jin Li; Sheng-Jun Zhang; Zhi-Xin Chen; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

3.  Signal transduction of gap junctional genes, connexin32, connexin43 in human hepatocarcinogenesis.

Authors:  Xiang-Dong Ma; Xing Ma; Yan-Fang Sui; Weng-Liang Wang; Chun-Mei Wang
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

4.  Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.

Authors:  Xiao-Zhong Wang; Xiao-Chun Chen; Yun-Xin Chen; Li-Juan Zhang; Dan Li; Feng-Lin Chen; Zhi-Xin Chen; Hong-Ying Chen; Qi-Ming Tao
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

5.  Successful rescuing a pregnant woman with severe hepatitis E infection and postpartum massive hemorrhage.

Authors:  Zhan-Sheng Jia; Yu-Mei Xie; Guo-Wu Yin; Jun-Rong Di; Wei-Pin Guo; Chang-Xing Huang; Xue-Fang Bai
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

6.  Expression of hepatitis B virus X protein in transgenic mice.

Authors:  Jun Xiong; Yu-Cheng Yao; Xiao-Yuan Zi; Jian-Xiu Li; Xin-Min Wang; Xu-Ting Ye; Shu-Min Zhao; Yong-Bi Yan; Hong-Yu Yu; Yi-Ping Hu
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.